Also, the compound inhibited cell migration through PI3K/Akt and Wnt/β-catenin signaling pathways [283] (Figure 6)—the pivotal elements in regulating PD-L1 protein expression—in BC cells [284]. Here, CD274 is linked to breast cancer.